239 related articles for article (PubMed ID: 31254004)
1. Critical regulation of atherosclerosis by the KCa3.1 channel and the retargeting of this therapeutic target in in-stent neoatherosclerosis.
Zhu YR; Jiang XX; Zhang DM
J Mol Med (Berl); 2019 Sep; 97(9):1219-1229. PubMed ID: 31254004
[TBL] [Abstract][Full Text] [Related]
2. Role of KCa3.1 Channels in Macrophage Polarization and Its Relevance in Atherosclerotic Plaque Instability.
Xu R; Li C; Wu Y; Shen L; Ma J; Qian J; Ge J
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):226-236. PubMed ID: 28062499
[TBL] [Abstract][Full Text] [Related]
3. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.
Toyama K; Wulff H; Chandy KG; Azam P; Raman G; Saito T; Fujiwara Y; Mattson DL; Das S; Melvin JE; Pratt PF; Hatoum OA; Gutterman DD; Harder DR; Miura H
J Clin Invest; 2008 Sep; 118(9):3025-37. PubMed ID: 18688283
[TBL] [Abstract][Full Text] [Related]
4. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A;
JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727
[TBL] [Abstract][Full Text] [Related]
5. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge.
Borovac JA; D'Amario D; Vergallo R; Porto I; Bisignani A; Galli M; Annibali G; Montone RA; Leone AM; Niccoli G; Crea F
Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):105-116. PubMed ID: 30285099
[TBL] [Abstract][Full Text] [Related]
6. In-Stent Atherosclerosis at a Crossroads: Neoatherosclerosis … or Paleoatherosclerosis?
Andreou I; Stone PH
Circulation; 2016 Nov; 134(19):1413-1415. PubMed ID: 27821417
[No Abstract] [Full Text] [Related]
7. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment.
Otsuka F; Byrne RA; Yahagi K; Mori H; Ladich E; Fowler DR; Kutys R; Xhepa E; Kastrati A; Virmani R; Joner M
Eur Heart J; 2015 Aug; 36(32):2147-59. PubMed ID: 25994755
[TBL] [Abstract][Full Text] [Related]
8. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
9. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
[TBL] [Abstract][Full Text] [Related]
11. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
[No Abstract] [Full Text] [Related]
12. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
Hansen LK
Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
[TBL] [Abstract][Full Text] [Related]
13. In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy).
Ueda Y; Matsuo K; Nishimoto Y; Sugihara R; Hirata A; Nemoto T; Okada M; Murakami A; Kashiwase K; Kodama K
JACC Cardiovasc Interv; 2015 May; 8(6):814-821. PubMed ID: 25999104
[TBL] [Abstract][Full Text] [Related]
14. Perilipin 2 levels are increased in patients with in-stent neoatherosclerosis: A clue to mechanisms of accelerated plaque formation after drug-eluting stent implantation.
Niccoli G; D'Amario D; Borovac JA; Santangelo E; Scalone G; Fracassi F; Vergallo R; Vetrugno V; Copponi G; Severino A; Liuzzo G; Imaeva A; Siracusano A; Crea F
Int J Cardiol; 2018 May; 258():55-58. PubMed ID: 29422264
[TBL] [Abstract][Full Text] [Related]
15. Neoatherosclerosis, plaque rupture and very late stent thrombosis of a first generation drug eluting stent treated with aspiration thrombectomy and newer generation drug eluting stent implantation.
Mustafa A; Daghem S; Farooq V; Fath-Ordoubadi F; Clarke B
Int J Cardiol; 2015 Dec; 201():648-9. PubMed ID: 26344489
[No Abstract] [Full Text] [Related]
16. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
[TBL] [Abstract][Full Text] [Related]
17. A case of severely calcified neoatherosclerosis after paclitaxel eluting stent implantation.
Yamamoto K; Sakakura K; Taniguchi Y; Wada H; Momomura SI; Fujita H
Cardiovasc Revasc Med; 2017 Sep; 18(6S1):52-53. PubMed ID: 28342839
[TBL] [Abstract][Full Text] [Related]
18. Macrophages facilitate post myocardial infarction arrhythmias: roles of gap junction and KCa3.1.
Fei YD; Wang Q; Hou JW; Li W; Cai XX; Yang YL; Zhang LH; Wei ZX; Chen TZ; Wang YP; Li YG
Theranostics; 2019; 9(22):6396-6411. PubMed ID: 31588225
[TBL] [Abstract][Full Text] [Related]
19. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.
Köhler R; Kaistha BP; Wulff H
Expert Opin Ther Targets; 2010 Feb; 14(2):143-55. PubMed ID: 20055714
[TBL] [Abstract][Full Text] [Related]
20. The calcium-activated potassium channel KCa3.1 plays a central role in the chemotactic response of mammalian neutrophils.
Henríquez C; Riquelme TT; Vera D; Julio-Kalajzić F; Ehrenfeld P; Melvin JE; Figueroa CD; Sarmiento J; Flores CA
Acta Physiol (Oxf); 2016 Jan; 216(1):132-45. PubMed ID: 26138196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
